Table of Contents Author Guidelines Submit a Manuscript
The Scientific World Journal
Volume 2013, Article ID 607285, 9 pages
http://dx.doi.org/10.1155/2013/607285
Research Article

Reestablishment of Ischemia-Reperfusion Liver Injury by N-Acetylcysteine Administration prior to a Preconditioning Iron Protocol

Molecular and Clinical Pharmacology Program, Institute of Biomedical Sciences, Faculty of Medicine, University of Chile, Casilla 70000, Santiago 7, Chile

Received 5 August 2013; Accepted 15 September 2013

Academic Editors: M. Enjoji and G. K. Glantzounis

Copyright © 2013 Virginia Fernández et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. N. R. Banga, S. Homer-Vanniasinkam, A. Graham, A. Al-Mukhtar, S. A. White, and K. R. Prasad, “Ischaemic preconditioning in transplantation and major resection of the liver,” British Journal of Surgery, vol. 92, no. 5, pp. 528–538, 2005. View at Publisher · View at Google Scholar · View at Scopus
  2. B. Fellström, L. M. Aküyrek, U. Backman, E. Larsson, J. Melin, and L. Zezina, “Postischemic reperfusion injury and allograft arteriosclerosis,” Transplantation Proceedings, vol. 30, no. 8, pp. 4278–4280, 1998. View at Publisher · View at Google Scholar · View at Scopus
  3. H. Jaeschke and B. L. Woolbright, “Current strategies to minimize hepatic ischemia-reperfusion injury by targeting reactive oxygen species,” Transplantation Reviews, vol. 26, no. 2, pp. 103–114, 2012. View at Publisher · View at Google Scholar · View at Scopus
  4. V. Fernández, G. Tapia, and L. A. Videla, “Recent advances in liver preconditioning: thyroid hormone, n-3 long-chain polyunsaturated fatty acids and iron,” World Journal of Hepatology, vol. 27, pp. 119–128, 2012. View at Google Scholar
  5. V. Fernández, I. Castillo, G. Tapia et al., “Thyroid hormone preconditioning: protection against ischemia-reperfusion liver injury in the rat,” Hepatology, vol. 45, no. 1, pp. 170–177, 2007. View at Publisher · View at Google Scholar · View at Scopus
  6. J. Zúñiga, F. Venegas, M. Villarreal et al., “Protection against in vivo liver ischemia-reperfusion injury by n-3 long-chain polyunsaturated fatty acids in the rat,” Free Radical Research, vol. 44, pp. 854–863, 2010. View at Google Scholar
  7. M. Mardones, R. Valenzuela, P. Romanque et al., “Prevention of liver ischemia reperfusion injury by a combined thyroid hormone and fish oil protocol,” Journal of Nutritional Biochemistry, vol. 23, pp. 1113–1120, 2012. View at Publisher · View at Google Scholar · View at Scopus
  8. M. Galleano, G. Tapia, S. Puntarulo, P. Varela, L. A. Videla, and V. Fernández, “Liver preconditioning induced by iron in a rat model of ischemia/reperfusion,” Life Sciences, vol. 89, no. 7-8, pp. 221–228, 2011. View at Publisher · View at Google Scholar · View at Scopus
  9. B. Metzler, J. Jehle, I. Theurl et al., “Short term protective effects of iron in a murine model of ischemia/reperfusion,” BioMetals, vol. 20, no. 2, pp. 205–215, 2007. View at Publisher · View at Google Scholar · View at Scopus
  10. J. P. Munoz, M. Chiong, L. García et al., “Iron induces protection and necrosis in cultured cardiomyocytes: role of reactive oxygen species and nitric oxide,” Free Radical Biology and Medicine, vol. 48, no. 4, pp. 526–534, 2010. View at Publisher · View at Google Scholar · View at Scopus
  11. A. Brand, E. Schonfeld, I. Isharel, and E. Yavin, “Docosahexaenoic acid-dependent iron accumulation in oligodendroglia cells protects from hydrogen peroxide-induced damage,” Journal of Neurochemistry, vol. 105, no. 4, pp. 1325–1335, 2008. View at Publisher · View at Google Scholar · View at Scopus
  12. S. Puntarulo and M. Galleano, “Forms of iron binding in the cells and the chemical features of chelation therapy,” Mini-Reviews in Medicinal Chemistry, vol. 9, no. 9, pp. 1136–1146, 2009. View at Publisher · View at Google Scholar · View at Scopus
  13. M. Chevion, S. Leibowitz, N. N. Aye et al., “Heart protection by ischemic preconditioning: a novel pathway initiated by iron and mediated by ferritin,” Journal of Molecular and Cellular Cardiology, vol. 45, no. 6, pp. 839–845, 2008. View at Publisher · View at Google Scholar · View at Scopus
  14. J. Chen-Roetling, J. Sinanan, and R. F. Regan, “Effect of iron chelators on methemoglobin and thrombin preconditioning,” Translational Stroke Research, vol. 3, pp. 452–459, 2012. View at Google Scholar
  15. P. Moldeus and I. A. Cotgreave, “N-acetylcysteine,” Methods in Enzymology, vol. 234, pp. 482–492, 1994. View at Publisher · View at Google Scholar · View at Scopus
  16. D. Harada, S. Naito, I. Hiraoka, and M. Otagiri, “In vivo kinetic analysis of covalent binding between N-acetyl-L-cysteine and plasma protein through the formation of mixed disulfide in rats,” Pharmaceutical Research, vol. 19, no. 5, pp. 615–620, 2002. View at Publisher · View at Google Scholar · View at Scopus
  17. F. Tietze, “Enzymic method for quantitative determination of nanogram amounts of total and oxidized glutathione: applications to mammalian blood and other tissues,” Analytical Biochemistry, vol. 27, no. 3, pp. 287–290, 1969. View at Google Scholar · View at Scopus
  18. H. A. Rüdiger, R. Graf, and P. Clavien, “Sub-lethal oxidative stress triggers the protective effects of ischemic preconditioning in the mouse liver,” Journal of Hepatology, vol. 39, no. 6, pp. 972–977, 2003. View at Publisher · View at Google Scholar · View at Scopus
  19. P. Romanque, A. Díaz, G. Tapia, S. Uribe-Echevarría, L. A. Videla, and V. Fernandez, “Delayed ischemic preconditioning protects against liver ischemia-reperfusion injury in vivo,” Transplantation Proceedings, vol. 42, no. 5, pp. 1569–1575, 2010. View at Publisher · View at Google Scholar · View at Scopus
  20. V. Fernández, G. Tapia, P. Varela et al., “Causal role of oxidative stress in liver preconditioning by thyroid hormone in rats,” Free Radical Biology and Medicine, vol. 44, no. 9, pp. 1724–1731, 2008. View at Publisher · View at Google Scholar · View at Scopus
  21. G. Leonarduzzi, B. Sottero, G. Testa, F. Biasi, and G. Poli, “New insights into redox-modulated cell signaling,” Current Pharmaceutical Design, vol. 17, no. 36, pp. 3994–4006, 2011. View at Google Scholar · View at Scopus
  22. M. Zafarullah, W. Q. Li, J. Sylvester, and M. Ahmad, “Molecular mechanisms of N-acetylcysteine actions,” Cellular and Molecular Life Sciences, vol. 60, no. 1, pp. 6–20, 2003. View at Publisher · View at Google Scholar · View at Scopus
  23. S. Bergamini, C. Rota, R. Canali et al., “N-acetylcysteine inhibits in vivo nitric oxide production by inducible nitric oxide synthase,” Nitric Oxide, vol. 5, no. 4, pp. 349–360, 2001. View at Publisher · View at Google Scholar · View at Scopus
  24. L. A. Videla, “Hormetic responses of thyroid hormone calorigenesis in the liver: association with oxidative stress,” IUBMB Life, vol. 62, no. 6, pp. 460–466, 2010. View at Publisher · View at Google Scholar · View at Scopus
  25. P. Morales, R. Vargas, L. A. Videla, and V. Fernández, “Kinetic changes of liver Nrf2 activity induced by iron administration,” Revista de Farmacología de Chile, vol. 5, p. 64, 2012, (abstract). View at Google Scholar
  26. P. Romanque, P. Cornejo, S. Valdés, and L. A. Videla, “Thyroid hormone administration induces rat liver Nrf2 activation: suppression by N-acetylcysteine pretreatment,” Thyroid, vol. 21, no. 6, pp. 655–662, 2011. View at Publisher · View at Google Scholar · View at Scopus
  27. G. Shen and A. Kong, “Nrf2 plays an important role in coordinated regulation of phase II drug metabolism enzymes and phase III drug transporters,” Biopharmaceutics and Drug Disposition, vol. 30, no. 7, pp. 345–355, 2009. View at Publisher · View at Google Scholar · View at Scopus
  28. S. K. Niture, J. W. Kaspar, J. Shen, and A. K. Jaiswal, “Nrf2 signaling and cell survival,” Toxicology and Applied Pharmacology, vol. 244, no. 1, pp. 37–42, 2010. View at Publisher · View at Google Scholar · View at Scopus
  29. S. Puntarulo, “Iron, oxidative stress and human health,” Molecular Aspects of Medicine, vol. 26, no. 4-5, pp. 299–312, 2005. View at Publisher · View at Google Scholar · View at Scopus
  30. S. B. Silverstein and G. M. Rodgers, “Parenteral iron therapy options,” American Journal of Hematology, vol. 76, no. 1, pp. 74–78, 2004. View at Publisher · View at Google Scholar · View at Scopus
  31. U. D. Bayraktar and S. Bayraktar, “Treatment of iron deficiency anemia associated with gastrointestinal tract diseases,” World Journal of Gastroenterology, vol. 16, no. 22, pp. 2720–2725, 2010. View at Publisher · View at Google Scholar · View at Scopus